EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin.

Increased transcriptional activity of beta-catenin resulting from Wnt/Wingless-dependent or -independent signaling has been detected in many types of human cancer, but the underlying mechanism of Wnt-independent regulation remains unclear. We demonstrate here that EGFR activation results in disruption of the complex of beta-catenin and alpha-catenin, thereby abrogating the inhibitory effect ...
of alpha-catenin on beta-catenin transactivation via CK2alpha-dependent phosphorylation of alpha-catenin at S641. ERK2, which is activated by EGFR signaling, directly binds to CK2alpha via the ERK2 docking groove and phosphorylates CK2alpha primarily at T360/S362, subsequently enhancing CK2alpha activity toward alpha-catenin phosphorylation. In addition, levels of alpha-catenin S641 phosphorylation correlate with levels of ERK1/2 activity in human glioblastoma specimens and with grades of glioma malignancy. This EGFR-ERK-CK2-mediated phosphorylation of alpha-catenin promotes beta-catenin transactivation and tumor cell invasion. These findings highlight the importance of the crosstalk between EGFR and Wnt pathways in tumor development.
Mesh Terms:
Amino Acid Sequence, Binding Sites, Casein Kinase II, Enzyme Activation, Epidermal Growth Factor, Extracellular Signal-Regulated MAP Kinases, Glioblastoma, Humans, Molecular Sequence Data, Neoplasm Invasiveness, Phosphorylation, Phosphoserine, Protein Binding, Receptor, Epidermal Growth Factor, Transcriptional Activation, alpha Catenin, beta Catenin
Mol. Cell
Date: Nov. 25, 2009
Download Curated Data For This Publication
197937
Switch View:
  • Interactions 7